CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bilcare Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bilcare Ltd
601, ICC Trade Tower
Phone: +91 2067490100p:+91 2067490100 PUNE, 411016  India Ticker: 526853526853
On 11/11/2022, the National Company Law Tribunal, Mumbai Bench admitted the petition filed by Assets Reconstruction Company (India) Limited and ordered the initiation of Corporate Insolvency Resolution Process (CIRP) against Bilcare Limited.
Business Summary
Bilcare Limited is an India-based company. The Company is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, and Research and Development (R&D) services. It has a single operating segment, namely Pharma Packaging Research Solutions. The Company offers a range of Pharma Packaging solutions, namely Blister Films, Blister Foils, Lidding Foils, Child-resistant (CR) Foils, and Laminations. Its R&D services include Formulation stability studies, Blister / Foil design & development, Pharma brand innovation, Analytical research & market study, and Packaging trials & audit. The Company has five subsidiaries, namely Bilcare GCS Limited, Bilcare Inc., Bilcare GCS Inc., Bilcare GCS Ireland Limited, Bilcare Pharma Solutions Limited, and Caprihans India Limited. Its annual manufacturing capacity is approximately 50000 tons. The Company has manufacturing facilities in Nashik, Pune, and Thane.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes---Yes

Industries
SIC Code Description
2671 Packaging paper and plastics film, coated and laminated
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Mohan H.Bhandari
Chief Financial Officer DeepaMathur 9/6/2023 9/6/2023
Compliance Officer, Company Secretary Sagar R.Baheti 1/31/2024 1/31/2024
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Bilcare Research AG Gewerbestrasse 12 Allschwil, Basel Land Switzerland

Business Names
Business Name
526853
Bilcare Agency GmbH
Bilcare Farmacseutica Embalagem E Pesquisas Ltda
17 additional Business Names available in full report.

General Information
Number of Employees: 73 (As of 3/31/2024)
Outstanding Shares: 23,545,231 (As of 9/30/2024)
Shareholders: 22,757
Stock Exchange: BOM
Fax Number: +91 2030257701


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025